Rising Adoption Of Point-Of-Care And At-Home Testing Driving Market Growth Due To Demand For Faster And More Convenient Health Assessments: Critical Driver Shaping the Rapid Diagnostic Test Kits Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Rapid Diagnostic Test Kits Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The fast-paced growth in the market size of rapid diagnostic test kits in the recent past is notable. The expansion is projected to rise from $22.66 billion in 2024 to $24.08 billion in 2025, showing a compound annual growth rate (CAGR) of 6.3%. This growth in the historical period is a result of the escalating occurrence of infectious diseases, increasing need for point-of-care testing, a heightened imperative for early detection during disease outbreaks, growing government financial support for controlling infectious diseases, and a rising trend of employing rapid tests in rural healthcare environments.

Rapid Diagnostic Test Kits Market Size Forecast: What's the Projected Valuation by 2029?
Anticipations are strong for a significant expansion in the market size of rapid diagnostic test kits in the next several years. With a compound annual growth rate (CAGR) of 6.0%, this market is projected to reach $30.44 billion by 2029. This growth during the predicted period can be credited to factors like increasing acceptance of diagnostic kits for home use, enhanced healthcare expenditure in underdeveloped regions, growing need for quick disease detection, widened support from international health entities, and a greater emphasis on distributed healthcare services. Upcoming trends during this period involve advancement in microfluidic-based diagnostic platforms, incorporation of smartphone technologies, evolving multiplex rapid test kits, breakthroughs in custom diagnostic solutions, and funding in the research and development of diagnostics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/rapid-diagnostic-test-kits-global-market-report

What Are the Drivers Transforming the Rapid Diagnostic Test Kits Market?
The increasingly growing focus on point-of-care and home-based testing is likely to stimulate the expansion of the rapid diagnostic test kits market in the future. This kind of testing, carried out at the site of patient care or in a person's home rather than traditional labs, offers speedy and practical results for prompt medical decisions. This shift is because individuals prefer quicker, more accessible health examinations that save them the hassle of visiting a lab, decrease wait times, and allow for immediate healthcare choices in their own environment. Rapid diagnostic test kits facilitate point-of-care and home-based testing by providing fast and trustworthy results, without the need for any specialist equipment, permitting swift health choices outside of conventional labs. For instance, in August 2022, the Centers for Disease Control and Prevention, a government agency based in the US, stated that the US recorded 10.7 million home-based COVID-19 test results in the period 2021- 2022, showcasing the increasing preference for self-testing over traditional methods. Hence, the rising focus on point-of-care and home-based testing is fuelling the expansion of the rapid diagnostic test kits market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24678&type=smp

What Long-Term Trends Will Define the Future of the Rapid Diagnostic Test Kits Market?
Leading businesses in the rapid diagnostic test kits industry, are working towards inventing unique solutions, such as saliva-centric pregnancy test kits, in order to outshine their competitors in the market. These saliva-based pregnancy test kits work as diagnostic instruments that ascertain pregnancy by checking a woman's saliva for hormonal fluctuations, particularly human chorionic gonadotropin (hCG), produced during the time of pregnancy. For example, Abingdon Health plc, a near-patient diagnostics provider based in the UK, launched the first rapid saliva-based pregnancy test known as Salistick in the UK and Ireland in February 2023. This marked a significant breakthrough in home pregnancy testing by offering a more user-friendly and clean solution as compared to the traditional urine-based tests. This highly reliable test identifies the pregnancy hormone ß-hCG in a woman's saliva, thus offering the flexibility to women to conduct early pregnancy detection at any place and time, simultaneously making the testing experience more individual and shareable.

Which Segments in the Rapid Diagnostic Test Kits Market Offer the Most Profit Potential?
The rapid diagnostic test kits market covered in this report is segmented -

1) By Product Type: Antigen Test Kits, Antibody Test Kits, Nucleic Acid Test Kits, Multi-Analyte Test Kits
2) By Technology: Fluorescent Immunoassay, Enzyme-Linked Immunosorbent Assay (ELISA), Colloidal Gold-Based Test, Lateral Flow Assays
3) By Application: Infectious Disease Testing, Cardiology Testing, Oncology Testing, Pregnancy And Fertility Testing, Toxicology Testing, Glucose Monitoring, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Home Care Settings, Pharmacies

Subsegments:
1) By Antigen Test Kits: COVID-19 Antigen Test Kits, Influenza Antigen Test Kits, Malaria Antigen Test Kits, Respiratory Syncytial Virus Antigen Test Kits, Streptococcus Antigen Test Kits
2) By Antibody Test Kits: HIV Antibody Test Kits, Hepatitis Antibody Test Kits, COVID-19 Antibody Test Kits, Dengue Antibody Test Kits, Syphilis Antibody Test Kits
3) By Nucleic Acid Test Kits: HIV Nucleic Acid Test Kits, Hepatitis B And C Nucleic Acid Test Kits, Human Papillomavirus Nucleic Acid Test Kits, Tuberculosis Nucleic Acid Test Kits, COVID-19 Nucleic Acid Test Kits
4) By Multi-Analyte Test Kits: Respiratory Panel Test Kits, Sexually Transmitted Infections Panel Test Kits, Gastrointestinal Panel Test Kits, Febrile Illness Panel Test Kits, Sepsis Marker Panel Test Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24678&type=smp

Which Firms Dominate the Rapid Diagnostic Test Kits Market by Market Share and Revenue in 2025?
Major companies operating in the rapid diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., OraSure Technologies Inc., Nova Biomedical Corporation, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, ACON Laboratories Inc., Fluxergy LLC, Lumos Diagnostics Holdings Limited, Abingdon Health plc, Abionic SA.

Which Regions Offer the Highest Growth Potential in the Rapid Diagnostic Test Kits Market?
North America was the largest region in the rapid diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid diagnostic test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24678

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.